She says she voted against the measure because the reconciliation bill won’t become law.
Medicare
Posted inPolitics
How Kathleen Rice Is Threatening the Biden Agenda
Rice and two other House Democrats oppose aggressive drug price reform, which provides the budget savings available to fuel spending in the Build Back Better Act.
Posted inHealth and Social Policy
House, Senate Spar Over Reducing Drug Prices
There’s overwhelming support among Democrats for finally allowing Medicare to negotiate with drug companies. But the details matter.
Posted inTAP
The 2022 Campaigns: Already All Laid Out
Today on TAP: The two parties’ separate universes
Posted inMoney, Politics, and Power
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs
House Oversight Committee report combats industry claims that lower drug prices would stifle innovation.
Posted inHealth and Social Policy
The Post-COVID Health Care System Is Out of Control
After gouging Americans for record pandemic profits, the health care industry sets its sights on even more.
Posted inHealth and Social Policy
Biden Would Rather Build an Entirely New Welfare State Than Touch the Hospitals
Health care improvements are minor and largely neglected in Biden’s new plan because he doesn’t want to arouse the ire of health care lobbyists.
Posted inTAP
Paying for Biden’s Program—Time to Get More Creative
Today on TAP: Alternatives to raising taxes
